Dietary Counselling Plus Omega-3 Supplementation in the Treatment of Generalized Anxiety Disorder

Summary

This study will assess the feasibility and acceptability of a combination intervention including dietary counselling and omega-3 fatty acid supplementation among women with generalized anxiety disorder. It will be randomized and wait-list controlled with 25 participants completing the 12-week intervention immediately and the other 25 participants completing the intervention after a 12-week wait period.

Conditions

• Generalized Anxiety Disorder

Interventions

COMBINATION_PRODUCT

Dietary Counselling combined with Omega-3 Supplementation

Dietary Counselling: Seven, bi-weekly counselling sessions over 12-weeks conducted by a licensed Naturopathic Doctor. Each session will be 45-60 minutes in length. The recommendations will be based on the Mediterranean diet and the results of a recent scoping review which summarized the research related to diet and anxiety. The intervention will include motivational interviewing, mindful eating techniques, goal setting and action planning. A range of resources related to meal planning, recipes, cooking education, shopping lists and tracking sheets will be provided in an individualized manner. Dietary Supplement: AquaOmega High EPA Omega-3 capsules will be taken at a dose of four capsules, once daily (containing a total of 3456 mg of omega-3 fatty acids: 2659mg of Eicosapentaenoic acid (EPA), 532mg of docosahexaenoic acid (DHA), and 800IU of Vitamin D), with a meal.

Sponsors & Collaborators

• McGill University

  collaborator OTHER

• Netherlands Open University

  collaborator OTHER

• Massachusetts General Hospital

  collaborator OTHER

• Ekhagastiftelsen

  collaborator OTHER

• AquaOmega

  collaborator UNKNOWN

• Lipid Analytical Laboratories Inc

  collaborator UNKNOWN

• Mitacs

  collaborator INDUSTRY

• The Canadian College of Naturopathic Medicine

  lead OTHER

Principal Investigators

• Monique Aucoin, ND MSc · Canadian College of Naturopathic Medicine

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

65 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2022-08-12

Primary Completion

2023-11-30

Completion

2023-11-30

Countries

• Canada

Study Locations